Marco Tagliamento (@m_tagliamento) 's Twitter Profile
Marco Tagliamento

@m_tagliamento

Assist Prof @UniGenova & Med Onc @SanMartino_Ge | Former @IASLC ILCF Research Fellow & Med Onc @GustaveRoussy | Clinical/Translational Research

ID: 1259920471

linkhttp://linkedin.com/in/marco-tagliamento calendar_today11-03-2013 16:53:23

633 Tweet

1,1K Followers

499 Following

Marco Tagliamento (@m_tagliamento) 's Twitter Profile Photo

Glad to represent Ospedale San Martino Genova at the general assembly and scientific conference of Organisation of European Cancer Institutes in Helsinki 🇫🇮 during the 2024 Oncology Days, the annual event of the Organisation of European Cancer Institutes. 🇪🇺 OncoAlert

Glad to represent <a href="/SanMartino_Ge/">Ospedale San Martino Genova</a> at the general assembly and scientific conference of <a href="/OECI_EEIG/">Organisation of European Cancer Institutes</a> in Helsinki 🇫🇮 during the 2024 Oncology Days, the annual event of the Organisation of European Cancer Institutes. 🇪🇺
<a href="/OncoAlert/">OncoAlert</a>
Accademia Medicina (@accmedorg) 's Twitter Profile Photo

Key papers oncologia Pubblicazione n. 62 LUNG A cura di Marco Tagliamento (GE), Lucrezia Barcellini (GE) Per visualizzare la pubblicazione: keypapers.it/keypapers-62

Key papers oncologia

Pubblicazione n. 62
LUNG
A cura di <a href="/M_Tagliamento/">Marco Tagliamento</a> (GE), Lucrezia Barcellini (GE)

Per visualizzare la pubblicazione:
keypapers.it/keypapers-62
Marco Tagliamento (@m_tagliamento) 's Twitter Profile Photo

In #CancerTreatmentReviews we addressed the use of #ctDNA in localized #NSCLC, including: 🧪Techniques for ctDNA detection 🩸Current main applications 🧬Future directions Open access: doi.org/10.1016/j.ctrv… Arianna Marinello, MD Filippo Dall'Olio Benjamin Besse Jordi Remon OncoAlert

In #CancerTreatmentReviews we addressed the use of #ctDNA in localized #NSCLC, including:
🧪Techniques for ctDNA detection
🩸Current main applications
🧬Future directions

Open access: doi.org/10.1016/j.ctrv…

<a href="/AriMarinel/">Arianna Marinello, MD</a> <a href="/FilippoDallOlio/">Filippo Dall'Olio</a> <a href="/BenjaminBesseMD/">Benjamin Besse</a> <a href="/JordiRemon/">Jordi Remon</a> <a href="/OncoAlert/">OncoAlert</a>
Camilla Satragno (@camisatragno) 's Twitter Profile Photo

Congrats to Roberta Grassi and Marco Tagliamento for their outstanding talks 🫁🔬at the AIOM giovani congress in Florence! 🎉 Great job to everyone who presented in their sessions⭐️Looking forward to more insightful discussions and collaborations!

Congrats to Roberta Grassi and <a href="/M_Tagliamento/">Marco Tagliamento</a> for their outstanding talks 🫁🔬at the <a href="/AIOMtweet/">AIOM</a> giovani congress in Florence! 🎉 
Great job to everyone who presented in their sessions⭐️Looking forward to more insightful discussions and collaborations!
Stephen V Liu, MD (@stephenvliu) 's Twitter Profile Photo

While amylase & lipase elevation often seen in trials of targeted agents, actual clinical pancreatitis is uncommon. In this retrospective report Clinical Lung Cancer from Drs. Meyer May-Lucie Mihaela Aldea and team, incidence of clinical pancreatitis was .08%! clinical-lung-cancer.com/article/S1525-…

Marco Tagliamento (@m_tagliamento) 's Twitter Profile Photo

Presidential #WCLC24. Neoadjuvant CT+IT vs perioperative IT. We still don't know what the best strategy is after this analysis. We are comparing two selected populations: patients who had surgery in CM 816 (83%) and those who had surgery+adjuvant IT in CM 77T (62% !!). IASLC

Presidential #WCLC24. 
Neoadjuvant CT+IT vs perioperative IT.
We still don't know what the best strategy is after this analysis.
We are comparing two selected populations: patients who had surgery in CM 816 (83%) and those who had surgery+adjuvant IT in CM 77T (62% !!).
<a href="/IASLC/">IASLC</a>
Marco Tagliamento (@m_tagliamento) 's Twitter Profile Photo

Join us today at the #WCLC24 Educational Session “Immunotherapy: Moving Beyond PD-1/PD-L1 and CTLA4” Thrilled to take part! 📍 Room 30DE ⏱ 2.00 PM to 3.15 PM IASLC Noemi Reguart OncoAlert #LCSM

Join us today at the #WCLC24 Educational Session “Immunotherapy: Moving Beyond PD-1/PD-L1 and CTLA4”
Thrilled to take part!

📍 Room 30DE
⏱ 2.00 PM to 3.15 PM

<a href="/IASLC/">IASLC</a> <a href="/NReguart/">Noemi Reguart</a> <a href="/OncoAlert/">OncoAlert</a> #LCSM